tradingkey.logo

BRIEF-Ausperbio Secures $73 Million In Series B Financing To Advance Functional Cure For Chronic Hepatitis B

ReutersDec 26, 2024 11:13 PM

-

  • AUSPERBIO SECURES $73 MILLION IN SERIES B FINANCING TO ADVANCE FUNCTIONAL CURE FOR CHRONIC HEPATITIS B

  • AUSPERBIO THERAPEUTICS- ROUND WAS LED BY HANKANG CAPITAL, WITH PARTICIPATION FROM SHERPA CAPITAL, CDH INVESTMENTS

Source text: ID:nPn4NzlpBa

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: For information purposes only. Past performance is not indicative of future results.